PATH conducted a study on behalf of the HPV Vaccine Acceleration Program Partners Initiative (HAPPI) Consortium to obtain insights into how switching to a single-dose schedule has impacted HPV vaccination programs in low- and middle-income countries and to gather insights for ongoing program planning and sustainability with a single-dose schedule. PATH conducted 35 semi-structured key informant interviews with national and subnational stakeholders in Burkina Faso, Ethiopia, and Solomon Islands to explore the operational aspects of switching from a two-dose to a one-dose HPV vaccination schedule across key thematic areas of the immunization program. This report shares high-level results from the study.
HPV-INTRO-SINGLE
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|
| Changes in HPV Vaccination Coverage, Implementation, and Sustainability Following the Switch to a Single-Dose Schedule: A Mixed-Methods Analysis | International Vaccine Access Center (IVAC) | 2026 | Report | English |
| Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second Edition | World Health Organization (WHO) | 2024 | Guidance | English |
| HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation | PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health | 2023 | Guidance | English, French, Portuguese, Russian, Spanish |
| Review of Existing Evidence on Single-Dose HPV Vaccination | Single dose consortium | 2022 | Presentation | English, French |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | PATH | 2025 | Report | English |
PORTFOLIO-LESSONS
This resource appears in the following Hot Topic page:
The resource is included in the following table:
| Title | Author | Year | Type | Language |
|---|
| A Switch for Sustainability in Ghana's Rotavirus Vaccine Program | George Armah | 2020 | Case study | English |
| Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program | PATH | 2020 | Case study | Arabic, English, Russian, French |
| Economic implications of switching to the hexavalent infant vaccine in an immunization program in India | Pawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari | 2026 | Journal article | English |
| Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings | Dose Per Container Partnership (DPCP), JSI | 2019 | Case study | English |
| The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia | Kirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass | 2020 | Journal article | English |
| The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact Analysis | PATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health | 2021 | Report | Russian |
| The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands | PATH | 2025 | Report | English |
| The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questions | PATH | 2022 | Report | English |
Added by: HAPPI
Added on: 2025-11-25 21:02:35
Hits: 868
